Integrated BioPharma Inc. (OTCMKTS:INBP – Get Free Report) traded up 2.7% during trading on Monday . The stock traded as high as $0.39 and last traded at $0.38. 4,948 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 28,837 shares. The stock had previously closed at $0.37.
Integrated BioPharma Stock Performance
The company has a quick ratio of 1.92, a current ratio of 4.12 and a debt-to-equity ratio of 0.01. The stock has a market cap of $11.77 million, a P/E ratio of 38.04 and a beta of 0.47. The firm’s 50-day moving average is $0.31 and its two-hundred day moving average is $0.30.
Integrated BioPharma Company Profile
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.
Featured Articles
- Five stocks we like better than Integrated BioPharma
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
- A U.S. “birthright” claim worth trillions – activated quietly
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
